Monday 30 September 2024

• 12:00 - Using high-throughout genetic and genomic screens to understand the biological basis of inflammatory bowel disease and deliver precision medicine
  In person only
  Dr Carl Anderson (Wellcome Sanger Institute)
  Kennedy Institute Seminars